Equity-research swarm on an investment thesis

Context

A markets research desk drafts a thesis on a covered name ahead of an earnings print. A research agent assembles filings, transcripts, and consensus; a risk agent stress-tests the downside and the crowded-trade angle; a writer drafts the note; and a compliance critic checks every claim for MNPI, selective disclosure, and unsupported price-target language.

The decision

The compliance critic is non-negotiable in a regulated research function — it's a surveillance control, not a nicety. That's what justifies the multi-agent cost here.

What most miss

In markets the risk isn't a weak thesis — it's a well-argued note that trips a disclosure or MNPI line. The critic is the control that keeps research publishable.

Stakes

A single compliance slip in published research is a regulatory and franchise event; the inference cost is a rounding error against it.